why is tirzepatide being discontinued FDA has announced that the shortage of #tirzepatide, the ingredient in Lilly's Mounjaro and Zepbound, has been resolved. Compounding #pharmacies are required to cease Adults with obesity who discontinue

At the end of the day, the right treatment depends on the person

doi: 10.1038/s41586-020-03045-2 115 MichalekRDGerrietsVAJacobsSRMacintyreANMacIverNJMasonEFet al

The psychological impact of not recognizing your own body, of clothes that do not fit, of a world that celebrates "bouncing back" while offering no meaningful help, is real and documented

Mornigo R, Vidal J, Lacy AM, Delgado S, Casamitjana R, Gomis R

It comes in brand variants like Wegovy, explicitly meant for weight management, and Ozempic, for type 2 diabetes management

however, both hyperglycemia and hyperinsulinemia in diabetes can elicit cell damage responses and induce neoplastic transformation and cancer progression [5]